225 related articles for article (PubMed ID: 28205613)
1. PAK4 interacts with p85 alpha: implications for pancreatic cancer cell migration.
King H; Thillai K; Whale A; Arumugam P; Eldaly H; Kocher HM; Wells CM
Sci Rep; 2017 Feb; 7():42575. PubMed ID: 28205613
[TBL] [Abstract][Full Text] [Related]
2. A PAK4-LIMK1 pathway drives prostate cancer cell migration downstream of HGF.
Ahmed T; Shea K; Masters JR; Jones GE; Wells CM
Cell Signal; 2008 Jul; 20(7):1320-8. PubMed ID: 18424072
[TBL] [Abstract][Full Text] [Related]
3. PAK4 kinase activity and somatic mutation promote carcinoma cell motility and influence inhibitor sensitivity.
Whale AD; Dart A; Holt M; Jones GE; Wells CM
Oncogene; 2013 Apr; 32(16):2114-20. PubMed ID: 22689056
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signaling.
Tabusa H; Brooks T; Massey AJ
Mol Cancer Res; 2013 Feb; 11(2):109-21. PubMed ID: 23233484
[TBL] [Abstract][Full Text] [Related]
5. Pak4, a novel Gab1 binding partner, modulates cell migration and invasion by the Met receptor.
Paliouras GN; Naujokas MA; Park M
Mol Cell Biol; 2009 Jun; 29(11):3018-32. PubMed ID: 19289496
[TBL] [Abstract][Full Text] [Related]
6. PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways.
Fu X; Feng J; Zeng D; Ding Y; Yu C; Yang B
Biosci Rep; 2014 Apr; 34(2):. PubMed ID: 27919028
[TBL] [Abstract][Full Text] [Related]
7. p-21 activated kinase 4 promotes proliferation and survival of pancreatic cancer cells through AKT- and ERK-dependent activation of NF-κB pathway.
Tyagi N; Bhardwaj A; Singh AP; McClellan S; Carter JE; Singh S
Oncotarget; 2014 Sep; 5(18):8778-89. PubMed ID: 25238288
[TBL] [Abstract][Full Text] [Related]
8. Activated-PAK4 predicts worse prognosis in breast cancer and promotes tumorigenesis through activation of PI3K/AKT signaling.
He LF; Xu HW; Chen M; Xian ZR; Wen XF; Chen MN; Du CW; Huang WH; Wu JD; Zhang GJ
Oncotarget; 2017 Mar; 8(11):17573-17585. PubMed ID: 28407679
[TBL] [Abstract][Full Text] [Related]
9. PAK4 confers the malignance of cervical cancers and contributes to the cisplatin-resistance in cervical cancer cells via PI3K/AKT pathway.
Shu XR; Wu J; Sun H; Chi LQ; Wang JH
Diagn Pathol; 2015 Sep; 10():177. PubMed ID: 26411419
[TBL] [Abstract][Full Text] [Related]
10. The role of p21-activated kinase 4 in the progression of oral squamous cell carcinoma by targeting PI3K-AKT signaling pathway.
Zhang L; Lin S; Zhang Z; Yan C; Liu F
Clin Transl Oncol; 2023 Mar; 25(3):739-747. PubMed ID: 36593383
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic PAK4 regulates Smad2/3 axis involving gastric tumorigenesis.
Wang C; Li Y; Zhang H; Liu F; Cheng Z; Wang D; Wang G; Xu H; Zhao Y; Cao L; Li F
Oncogene; 2014 Jun; 33(26):3473-84. PubMed ID: 23934187
[TBL] [Abstract][Full Text] [Related]
12. p21-Activated kinase 3 promotes cancer stem cell phenotypes through activating the Akt-GSK3β-β-catenin signaling pathway in pancreatic cancer cells.
Wu HY; Yang MC; Ding LY; Chen CS; Chu PC
Cancer Lett; 2019 Aug; 456():13-22. PubMed ID: 31051214
[TBL] [Abstract][Full Text] [Related]
13. Copy number alterations in pancreatic cancer identify recurrent PAK4 amplification.
Chen S; Auletta T; Dovirak O; Hutter C; Kuntz K; El-ftesi S; Kendall J; Han H; Von Hoff DD; Ashfaq R; Maitra A; Iacobuzio-Donahue CA; Hruban RH; Lucito R
Cancer Biol Ther; 2008 Nov; 7(11):1793-802. PubMed ID: 18836286
[TBL] [Abstract][Full Text] [Related]
14. Targeting PAK4 Inhibits Ras-Mediated Signaling and Multiple Oncogenic Pathways in High-Risk Rhabdomyosarcoma.
Dasgupta A; Sierra L; Tsang SV; Kurenbekova L; Patel T; Rajapakse K; Shuck RL; Rainusso N; Landesman Y; Unger T; Coarfa C; Yustein JT
Cancer Res; 2021 Jan; 81(1):199-212. PubMed ID: 33168646
[TBL] [Abstract][Full Text] [Related]
15. PAK4 is activated via PI3K in HGF-stimulated epithelial cells.
Wells CM; Abo A; Ridley AJ
J Cell Sci; 2002 Oct; 115(Pt 20):3947-56. PubMed ID: 12244132
[TBL] [Abstract][Full Text] [Related]
16. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991
[TBL] [Abstract][Full Text] [Related]
17. PAK4: a pluripotent kinase that regulates prostate cancer cell adhesion.
Wells CM; Whale AD; Parsons M; Masters JR; Jones GE
J Cell Sci; 2010 May; 123(Pt 10):1663-73. PubMed ID: 20406887
[TBL] [Abstract][Full Text] [Related]
18. TGF-β promotes PI3K-AKT signaling and prostate cancer cell migration through the TRAF6-mediated ubiquitylation of p85α.
Hamidi A; Song J; Thakur N; Itoh S; Marcusson A; Bergh A; Heldin CH; Landström M
Sci Signal; 2017 Jul; 10(486):. PubMed ID: 28676490
[TBL] [Abstract][Full Text] [Related]
19. Group II p21-activated kinase, PAK4, is needed for activation of focal adhesion kinases, MAPK, GSK3, and β-catenin in rat pancreatic acinar cells.
Ramos-Álvarez I; Lee L; Jensen RT
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G490-G503. PubMed ID: 31984786
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-433 inhibits cell proliferation in hepatocellular carcinoma by targeting p21 activated kinase (PAK4).
Xue J; Chen LZ; Li ZZ; Hu YY; Yan SP; Liu LY
Mol Cell Biochem; 2015 Jan; 399(1-2):77-86. PubMed ID: 25410752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
